Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Procore Technologies Inc is a software-application business based in the US. Procore Technologies shares (PCOR) are listed on the NYSE and all prices are listed in US Dollars. Procore Technologies employs 1,920 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$98.00|
|52-week range||$78.96 - $108.75|
|50-day moving average||$93.03|
|200-day moving average||$92.52|
|Wall St. target price||$111.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-5.64|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-20)||-2.10%|
|1 month (2021-09-27)||2.08%|
|3 months (2021-07-27)||-1.38%|
|6 months (2021-04-23)||N/A|
|1 year (2020-10-23)||N/A|
|2 years (2019-10-23)||N/A|
|3 years (2018-10-23)||N/A|
|5 years (2016-10-23)||N/A|
|Revenue TTM||$448.1 million|
|Gross profit TTM||$328.8 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$13.2 billion|
TTM: trailing 12 months
There are currently 2.3 million Procore Technologies shares held short by investors – that's known as Procore Technologies's "short interest". This figure is 20.1% up from 1.9 million last month.
There are a few different ways that this level of interest in shorting Procore Technologies shares can be evaluated.
Procore Technologies's "short interest ratio" (SIR) is the quantity of Procore Technologies shares currently shorted divided by the average quantity of Procore Technologies shares traded daily (recently around 348068.22289157). Procore Technologies's SIR currently stands at 6.64. In other words for every 100,000 Procore Technologies shares traded daily on the market, roughly 6640 shares are currently held short.
To gain some more context, you can compare Procore Technologies's short interest ratio against those of similar companies.
However Procore Technologies's short interest can also be evaluated against the total number of Procore Technologies shares, or, against the total number of tradable Procore Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Procore Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Procore Technologies shares in existence, roughly 20 shares are currently held short) or 0.0393% of the tradable shares (for every 100,000 tradable Procore Technologies shares, roughly 39 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Procore Technologies.
Find out more about how you can short Procore Technologies stock.
We're not expecting Procore Technologies to pay a dividend over the next 12 months.
You may also wish to consider:
Procore Technologies, Inc. provides a cloud-based construction management platform and related software products. The company enables stakeholders in the construction industry, such as owners, general contractors, specialty contractors, architects, and engineers, to collaborate on construction projects. It offers products, such as Preconstruction that facilitates collaboration between internal and external stakeholders during the planning, budgeting, estimating, bidding, and partner selection phase of a construction project; Project Management, which enables real-time collaboration, information storage, design, BIM model clash detection, and regulation compliance for teams on the jobsite and in the back office; Resource Management that helps customers track labor productivity and manage profitability on construction projects; and Financial Management, which provides customers with visibility into the financial health of their individual construction projects and portfolios, as well as facilitate untethered access to financial data, linking the field, and the office in real-time. The company serves customers, including owners, general contractors, and specialty contractors operating in the commercial, residential, industrial, and infrastructure segments of the construction industry. It primarily sells subscriptions to access its products on computers, smartphones, and tablets through any web browser or from its mobile application available for iOS and Android platforms through its direct sales team. It has operations in the United States, Canada, Mexico, the United Kingdom, Ireland, Australia, New Zealand, Singapore, and the United Arab Emirates.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.